With regard to combined level of MEG3 methylation in plasma and prognosis, we divided the cervical cancer patients into 2 groups: group 1, methylated group (n = 90); group 2, partially methylated (M and U) and unmethylated group (n = 78). Here, MEG3 is linked to cervical carcinoma.